General Information of the Compound
| Compound ID |
CP0428410
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-fluoro-N-[4-[5-[3-(4-fluoropiperidin-1-yl)propylamino]-1,3,4-oxadiazol-2-yl]phenyl]benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H25F2N5O2
|
||||||||||||||||||
| Molecular Weight |
441.482
|
||||||||||||||||||
| Canonical SMILES |
FC1CCN(CCCNc2nnc(o2)-c2ccc(NC(=O)c3ccccc3F)cc2)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H25F2N5O2/c24-17-10-14-30(15-11-17)13-3-12-26-23-29-28-22(32-23)16-6-8-18(9-7-16)27-21(31)19-4-1-2-5-20(19)25/h1-2,4-9,17H,3,10-15H2,(H,26,29)(H,27,31)
Show/Hide
|
||||||||||||||||||
| InChIKey |
XLBYUGKZWZMFEL-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01846, Neuronal acetylcholine receptor subunit alpha-7
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2